HAG
CVS icon

HF Advisory Group’s CVS Health CVS Stock Holding History

HF Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Buy
5,288
+53
+1% +$4.73K 0.17% 131
2026
Q1 		$376K Buy
5,235
+589
+13% +$45.4K 0.13% 135
2025
Q4 		$369K Sell
4,646
-573
-11% -$45.2K 0.13% 138
2025
Q3 		$393K Buy
5,219
+145
+3% +$9.94K 0.14% 136
2025
Q2 		$350K Sell
5,074
-1,312
-21% -$86K 0.14% 136
2025
Q1 		$433K Sell
6,386
-221
-3% -$13.2K 0.19% 127
2024
Q4 		$297K Sell
6,607
-7,620
-54% -$427K 0.14% 135
2024
Q3 		$895K Sell
14,227
-3,383
-19% -$197K 0.42% 90
2024
Q2 		$1.04M Buy
17,610
+2,976
+20% +$186K 0.54% 71
2024
Q1 		$1.17M Buy
14,634
+708
+5% +$54.1K 0.65% 56
2023
Q4 		$1.1M Buy
13,926
+3,643
+35% +$259K 0.7% 51
2023
Q3 		$730K Sell
10,283
-476
-4% -$33.7K 0.54% 67
2023
Q2 		$744K Buy
10,759
+1,067
+11% +$75.9K 0.59% 63
2023
Q1 		$720K Buy
9,692
+1,472
+18% +$123K 0.64% 57
2022
Q4 		$766K Buy
+8,220
New +$793K 0.77% 48

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

HF Advisory Group's CVS Position: Q2 2026 in Review

HF Advisory Group increased its CVS Health (CVS) stake by 1% in Q2 2026, buying an estimated $4.73K and bringing the position to 5,288 shares worth $547K. The position accounts for 0.17% of the portfolio, ranked #131.

HF Advisory Group first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.17M in Q1 2024. 348 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • HF Advisory Group held 5,288 shares of CVS Health worth $547K as of Q2 2026.
  • HF Advisory Group bought 53 CVS Health shares in Q2 2026, an estimated $4.73K.
  • CVS Health made up 0.17% of HF Advisory Group's portfolio in Q2 2026, its #131 holding.
  • HF Advisory Group first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • HF Advisory Group's CVS Health position peaked at $1.17M in Q1 2024.
  • 348 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on HF Advisory Group's 13F filing for Q2 2026, filed 9 Jul 2026.